SCHEMBL20387888

SCHEMBL20387888

C=C/C=C\C(=C)N(C)C(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26496110 0.80
SCHEMBL19187503 0.79
SCHEMBL23095461 0.79 TSHR (0.32)
SCHEMBL19176571 0.76
SCHEMBL23917569 0.76 CHRNB2 (0.31)
SCHEMBL18522652 0.75
SCHEMBL19628908 0.75
SCHEMBL21658614 0.75
SCHEMBL25548545 0.74
SCHEMBL21994153 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024040169-A2 METHODS AND COMPOSITIONS FOR TREATING CANCER WITH CANCER-BINDING ADJUVANTS THE UNIVERSITY OF CHICAGO (US) 2024-02-22 WO disclosed
WO-2023192961-A2 LIGAND-PAYLOAD CONJUGATES PYXIS ONCOLOGY, INC. (US) 2023-10-05 WO disclosed
EP-2968585-B1 PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF MEDIMMUNE LTD (GB) 2018-07-18 EP disclosed